This page features scientific coverage from ACC.20/WCC including Expert Analyses, Patient Case Quizzes, Summary Slides, and Visual Abstracts. This post-meeting content was developed by the ACC.org Editorial Board to reinforce teaching points from the hottest late-breaking clinical trials and education presented during ACC.20/WCC.
|AUGUSTUS: How Long to Continue Aspirin After ACS/PCI in AFib Patients?
|COMPASS Diabetes: Role of Combination Antiplatelet and Anticoagulation Therapy in Diabetes and CVD
|POPular TAVI Cohort B: Antithrombotic Therapy After TAVI
|PRECOMBAT: Ten-Year Outcomes After DES vs. CABG for Left Main Coronary Disease
|PRONOMOS: Rivaroxaban vs. Enoxaparin in Nonmajor Orthopedic Surgery
|SPYRAL HTN-OFF MED Pivotal: Catheter-Based Renal Denervation in the Absence of Antihypertensive Medications
|TWILIGHT: Ticagrelor With and Without Aspirin in High-Risk Patients With Diabetes Mellitus Undergoing PCI
|VICTORIA: Vericiguat Global Study In Subjects With HFrEF
|VOYAGER PAD: Rivaroxaban For Prevention of CV and Limb Events After Lower Extremity Revascularization
|Additional ACC.20/WCC Coverage